关于COPD患者对治疗的坚持的疾病感知,认知和信仰 - - 一个系统性审查
Valentina Poletti1, Francesco Pagnini1, Paolo Banfi2
1Department of Psychology, Università Cattolica Del Sacro Cuore, Milan, Italy.
患者对慢性阻塞性肺病 (COPD) 的看法显著影响治疗坚持. 了解这些信念是改善患者治疗结果和个性化治疗这种慢性呼吸道疾病的关键.
科学领域:
- 肺部医学 肺部医学
- 行为科学 行为科学
- 健康心理学 心理健康心理学
背景情况:
- 慢性阻塞性肺部疾病 (COPD) 是一种渐进的,不可逆转的呼吸系统疾病,需要持续坚持治疗.
- 不坚持是普遍存在的,影响了近一半的COPD患者,严重阻碍了有效的疾病管理.
- 患者对疾病的看法 (IP) 越来越被认为是影响患者遵守COPD治疗的潜在因素.
研究的目的:
- 系统地审查和综合现有关于COPD患者疾病感知,认知,信念和治疗坚持之间的关系的研究.
- 确定与坚持和不坚持COPD治疗相关的关键患者信仰和看法.
- 探索患者的主观观点如何影响对处方医疗方案的参与.
主要方法:
- 根据PRISMA指南进行了全面的系统审查.
- 在主要的科学数据库 (PubMed,Medline,Scopus等) 进行了搜索. 对于英语出版物而言.
- 数据提取和批判性评估由两个审稿人独立进行,以确保严格.
主要成果:
- 十四项研究证实了COPD的低坚持率,无论评估方法如何.
- 慢性肺炎通常被认为是一种永久的中度威胁,患者的知识有限.
- 感知到药物的必要性和护理人员的支持与更高的坚持相关;忘记和不信任是关键障碍.
结论:
- 疾病感知,认知,信念和COPD治疗坚持之间的联系是复杂和可变的.
- 认识到患者的主观观点对于开发有效的个性化干预至关重要.
- 增强的理解可以为未来的治疗策略提供信息,以改善COPD管理中的坚持和患者结果.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
